Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ABVC Biopharma | ABVC | Apr 25, 2024 | 1.59 | +7.43 |
Ac Immune SA | ACIU | Apr 25, 2024 | 2.29 | -3.38 |
Acacia Research | ACTG | Apr 25, 2024 | 4.89 | -1.81 |
Academy Sports and Outdoors | ASO | Apr 25, 2024 | 59.07 | +0.02 |
Acadia Healthcare | ACHC | Apr 25, 2024 | 73.38 | +3.08 |
Acadia Pharmaceuticals | ACAD | Apr 25, 2024 | 16.31 | -1.69 |
Acadia Realty Trust | AKR | Apr 25, 2024 | 17.38 | -0.46 |
Acasti Pharma A | ACST | Apr 25, 2024 | 2.93 | +0.98 |
Accel Entertainment | ACEL | Apr 25, 2024 | 11.30 | -1.74 |
Accelerate Diagnostics | AXDX | Apr 25, 2024 | 0.95 | +1.54 |
Accenture A | ACN | Apr 25, 2024 | 309.00 | -1.45 |
Acco Brands | ACCO | Apr 25, 2024 | 4.85 | -1.22 |
Accolade | ACCD | Apr 25, 2024 | 9.19 | -2.23 |
Accuray | ARAY | Apr 25, 2024 | 2.18 | -0.91 |
Ace Global Business Acquisition | ACBA | Apr 25, 2024 | 12.10 | 0.00 |
Ace Global Business Acquisition Unit | ACBAU | Apr 25, 2024 | 11.96 | 0.00 |
Acelyrin | SLRN | Apr 25, 2024 | 4.24 | -7.22 |
Achieve Life Sciences | ACHV | Apr 25, 2024 | 4.58 | +0.77 |
Achilles Therapeutics ADR | ACHL | Apr 25, 2024 | 0.77 | -1.20 |
ACI Worldwide | ACIW | Apr 25, 2024 | 32.77 | -1.68 |
Aclarion | ACON | Apr 25, 2024 | 0.39 | +36.35 |
Aclaris Therapeutics | ACRS | Apr 25, 2024 | 1.19 | +1.71 |
ACM Research A | ACMR | Apr 25, 2024 | 28.29 | +0.50 |
Acme United | ACU | Apr 25, 2024 | 40.64 | -1.38 |
ACNB | ACNB | Apr 25, 2024 | 33.20 | -2.30 |
Acorda Therapeutics | ACOR | Apr 25, 2024 | 0.88 | 0.00 |
ACRES Commercial Realty | ACR | Apr 25, 2024 | 13.66 | +0.52 |
ACRES Commercial Realty C Pref | ACR-C | Apr 25, 2024 | 24.16 | -0.16 |
ACRES Commercial Realty D Pref | ACR-D | Apr 25, 2024 | 20.58 | +0.20 |
Acrivon Therapeutics | ACRV | Apr 25, 2024 | 8.47 | -10.84 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.